Envestnet Asset Management »

Beam Therapeutics shares owned by Envestnet Asset Management

Quarter-by-quarter ownership of Beam Therapeutics (BEAM) shares owned by Envestnet Asset Management from 13F filings

Historical chart of Envestnet Asset Management investment in Beam Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Beam Therapeutics held by Envestnet Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Beam Therapeutics by Envestnet Asset Management

Quarter filed Position value Share count Share price at filing
2023-09-30 $244k 10k 24.05
2023-06-30 $487k 15k 31.93
2023-03-31 $394k 13k 30.62
2022-12-31 $298k 7.6k 39.11
2022-09-30 $266k 5.6k 47.67
2022-03-31 $204k 3.6k 57.43
2021-09-30 $431k 5.0k 87.07

More positions owned by Envestnet Asset Management

Ishares Tr Core S&p500 Etf (IVV)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Ishares Tr Core Total Usd (IUSB)
Vanguard Bd Index Fds Short Trm Bond (BSV)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Ishares Tr Core Us Aggbd Et (AGG)
Ishares Tr Msci Usa Qlt Fct (QUAL)
Microsoft Corporation (MSFT)
Vanguard Index Fds Value Etf (VTV)
Ishares Tr Eafe Value Etf (EFV)
Vanguard Index Fds Growth Etf (VUG)
Ishares Tr Core Msci Eafe (IEFA)
Vanguard Charlotte Fds Total Int Bd Etf (BNDX)
Ishares Tr Eafe Grwth Etf (EFG)
Ishares Tr Mbs Etf (MBB)

View all positions for Envestnet Asset Management

Top funds holding Beam Therapeutics

ARK Investment Management
Vanguard Group
Sumitomo Mitsui Trust Holdings
Nikko Asset Management Americas
Redmile Group
Yiheng Capital
Baillie Gifford & Co
Bellevue Group
Charles Schwab Investment Management
Dimensional Fund Advisors
Casdin Capital
Jpmorgan Chase & Co
Goldman Sachs Group
Tang Capital Management
Jane Street

View all funds holding Beam Therapeutics